Animal models of systemic sclerosis: their utility and limitations

References

• MayesMDLaceyJVJrBeebe-DimmerJPrevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US populationArthritis Rheum2003482246225512905479
   PubMed Web of Science ®Google Scholar
• VargaJAbrahamDSystemic sclerosis: a prototypic multisystem fibrotic disorderJ Clin Invest200711755756717332883
   PubMed Web of Science ®Google Scholar
• FanningGCWelshKIBunnCDu BoisRBlackCMHLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patientsBr J Rheumatol1998372012079569077
   PubMedGoogle Scholar
• DentonCPLapadulaGMouthonLMuller-LadnerURenal complications and scleroderma renal crisisRheumatology200948Suppl 3iii32iii3519487221
   PubMed Web of Science ®Google Scholar
• GreenMCSweetHOBunkerLETight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeletonAm J Pathol197682493512176891
   PubMed Web of Science ®Google Scholar
• ChatterjeeSMarkMEWooleyPHLawrenceWDMayesMDIncreased dermal elastic fibers in the tight skin mouseClin Exp Rheumatol20042261762015485016
   PubMed Web of Science ®Google Scholar
• GardiCMartoranaPAde SantiMMvan EvenPLungarellaGA biochemical and morphological investigation of the early development of genetic emphysema in tight-skin miceExp Mol Pathol1989503984102721656
   PubMed Web of Science ®Google Scholar
• WongAKOsbornTGMillerJGWicklineSAQuantification of ventricular remodeling in the tight-skin mouse cardiomyopathy with acoustic microscopyUltrasound Med Biol1993193653748356780
   PubMed Web of Science ®Google Scholar
• SiracusaLDMcGrathRMaQA tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutationGenome Res199663003138723723
   PubMed Web of Science ®Google Scholar
• SaitoSNishimuraHBrumeanuTDCharacterization of mutated protein encoded by partially duplicated fibrillin-1 gene in tight skin (TSK) miceMol Immunol19993616917610403482
   PubMed Web of Science ®Google Scholar
• MuraiCSaitoSKasturiKNBonaCASpontaneous occurrence of anti-fibrillin-1 autoantibodies in tight-skin miceAutoimmunity1998281511559867127
   PubMed Web of Science ®Google Scholar
• TanFKArnettFCAntohiSAutoantibodies to the extracellular matrix mircofibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseasesJ Immunol19991631066107210395706
   PubMed Web of Science ®Google Scholar
• TanFKArnettFCReveilleJDAutoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in a recognition and lack of correlation with specific clinical features and HLA allelesArthritis Rheum2000432464247111083269
   PubMed Web of Science ®Google Scholar
• TanFKStriversDNFosterMWAssociation of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a native American populationArthritis Rheum199841172917379778214
   PubMed Web of Science ®Google Scholar
• TanFKWangNKuwanaMAssociation of fibrillin 1 single-nucleotide polymorphisms haplotypes with systemic sclerosis in Chotaw and Japanese populationsArthritis Rheum20014489390111315929
   PubMed Web of Science ®Google Scholar
• BrinckmannJHunzelmannNEl-HallousEAbsence of autoantibodies against correctly folded recombinant fibrillin-1 protein in systemic sclerosis patientsArthritis Res Ther20057R1221R122616277674
   PubMed Web of Science ®Google Scholar
• WipffJGiraudMSibiliaJPolymorphic markers of the fibrillin-1 gene and systemic sclerosis in European Caucasian patientsJ Rheumatol20083564364918278837
   PubMed Web of Science ®Google Scholar
• WallisDDTanFKKieltyCMKimballMDArnettFCMilewiczDMAbnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma)Arthritis Rheum2001441855186411508439
   PubMed Web of Science ®Google Scholar
• LoeysBLGerberEERiegert-JohnsonDMutations in fibrillin-1 cause congenital scleroderma: stiff skin syndromeSci Trans Med201022323ra20
   PubMed Web of Science ®Google Scholar
• GerberEEGalloEMFontanaSCIntegrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of sclerodermaNature201350312613024107997
   PubMed Web of Science ®Google Scholar
• Sassi-GahaSLoughlinDTKapplerFTwo dicarbonyl compounds, 3-deoxyglucosone and methylglyoxal, differentially modulate dermal fibroblastsMatrix Biol20102912713419800404
   PubMed Web of Science ®Google Scholar
• LoughlinDTArtlettCM3-Deoxyglucosone-collagen alters human dermal fibroblast migration and adhesion: implications for impaired wound healing in patients with diabetesWound Repair Regen20091773974919769726
   PubMed Web of Science ®Google Scholar
• LoughlinDTArtlettCMModification of collagen by 3-deoxyglucosone alters wound healing through differential regulation of p38 MAP kinasePLoS One20116e1867621573155
   PubMed Web of Science ®Google Scholar
• LoughlinDTArtlettCMPrecursor of advanced glycation end products mediates ER-stress-induced caspase-3 activation of human dermal fibroblasts through NAD(P)H oxidase 4PLoS One20105e1109320559423
   PubMed Web of Science ®Google Scholar
• AkhmetshinaAVenalisPDeesCTreatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosisArthritis Rheum20096021922419116940
   PubMed Web of Science ®Google Scholar
• BadeaIVirtanenCVerrallRERosenbergAFoldvariMEffect of topical interferon-gamma gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ miceGene Ther20121997898722071972
   PubMed Web of Science ®Google Scholar
• YoshizakiAYanabaKOgawaAThe specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosisArthritis Rheum2011633086309721618208
   PubMed Web of Science ®Google Scholar
• YoshizakiAYanabaKYoshizakiATreatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosisArthritis Rheum2010622476248720506342
   PubMed Web of Science ®Google Scholar
• PetersJBallSTTight skin 2 (Tsk2/+)Mouse News Letter1986749192
   Google Scholar
• ChristnerPJSiracusaLDHawkinsDFA high resolution linkage map of the tight skin 2 (tsk2) locus: a mouse model for scleroderma (SSc) and other cutaneous fibrotic diseasesMamm Genome199676106128678985
   PubMed Web of Science ®Google Scholar
• ChristnerPJPetersJHawkinsDSiracusaLDJimenezSAThe tight skin 2 mouse. An animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltrationArthritis Rheum199538179117988849351
   PubMed Web of Science ®Google Scholar
• GentilettiJMcCloskeyLJArtlettCMPetersJJimenezSAChristnerPJDemonstration of autoimmunity in the tight skin-2 mouse: a model for sclerodermaJ Immunol20051752418242616081813
   PubMed Web of Science ®Google Scholar
• ChristnerPJHitrayaEGPetersJMcGrathRJimenezSATranscriptional activation of the alpha1(I) procollagen gene and up-regulation of alpha1(I) and alpha1(III) procollagen messenger RNA in dermal fibroblasts from tight skin 2 miceArthritis Rheum199841213221429870870
   PubMed Web of Science ®Google Scholar
• WooleyPHSudSLangendorferAT cells infiltrating the skin of Tsk2 scleroderma-like mice exhibit T cell receptor biasAutoimmunity19982791989583740
   PubMed Web of Science ®Google Scholar
• GruschwitzMSMoormannSKromerGPhenotypic analysis of skin infiltrates in comparison with peripheral blood lymphocytes, spleen cells and thymocytes in early avian sclerodermaJ Autoimmun199145775931777010
   PubMed Web of Science ®Google Scholar
• NguyenVASgoncRDietrichHWickGEndothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (scleroderma)J Autoimmun20001414314910677245
   PubMed Web of Science ®Google Scholar
• GershwinMEAbplanalpHCastlesJJCharacterization of a spontaneous disease of white leghorn chickens resembling progressive systemic sclerosis (scleroderma)J Exp Med1981153164016597252423
   PubMed Web of Science ®Google Scholar
• WordaMSgoncRDietrichHIn vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assayArthritis Rheum2003482605261413130480
   PubMed Web of Science ®Google Scholar
• EkWSahlqvistASCrooksLMapping QTL affecting a systemic sclerosis-like disorder in a cross between UCD-200 and red jungle fowl chickensDev Comp Immunol20123835235922796227
   PubMed Web of Science ®Google Scholar
• AsanoYIhnHYamaneKKuboMTamakiKImpaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblastsJ Clin Invest200411325326414722617
   PubMed Web of Science ®Google Scholar
• BrissettMVeraldiKLPilewskiJMMedsgerTAFeghali-BostwickCALocalized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3Arthritis Rheum20126427228021898349
   PubMed Web of Science ®Google Scholar
• RadstakeTRGorlovaORuedaBGenome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locusNat Genet20104242642920383147
   PubMed Web of Science ®Google Scholar
• FujimotoMTsutsuiHXinshouOInadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseasesInt Immunol20041630331414734616
   PubMed Web of Science ®Google Scholar
• FischerFRSantambrogioLLuoYBermanMAHancockWWDorfMEModulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expressionJ Neuroimmunol200011019520811024550
   PubMed Web of Science ®Google Scholar
• GruschwitzMSShoenfeldYKruppMAntinuclear antibody profile in UCD line 200 chickens: a model for progressive systemic sclerosisInt Arch Allergy Immunol19931003073138386962
   PubMed Web of Science ®Google Scholar
• RamanVQuillenKSloanJMAcquired Glanzmann thrombasthenia associated with Hodgkin lymphoma: rapid reversal of functional platelet defect with ABVD (adriamycin/bleomycin/vinblastine/dacarbazine) chemotherapyClin Lymphoma Myeloma Leuk201414e51e5424342105
   PubMedGoogle Scholar
• LewisTGNydorfEDIntralesional bleomycin for warts: a reviewJ Drugs Dermatol2006549950416774100
   PubMedGoogle Scholar
• InaokiMKawabataCNishijimaCYoshioNKitaTCase of bleomycin-induced sclerodermaJ Dermatol20123948248421955042
   PubMed Web of Science ®Google Scholar
• MountzJDDowns MinorMBTurnerRThomasTBRichardsFPiskoEBleomycin-induced cutaneous toxicity in the rat: analysis of histopathology and ultrastructure compared with progressive systemic sclerosis (scleroderma)Br J Dermatol19831086796866190497
   PubMed Web of Science ®Google Scholar
• FinchWRRodnanGPBuckinghamRBPrinceRKWinkelsteinABleomycin-induced sclerodermaJ Rheumatol198076516596160247
   PubMed Web of Science ®Google Scholar
• YamamotoTTakagawaSKatayamaIAnimal model of sclerotic skin. Local injections of bleomycin induces sclerosis skin mimicking sclerodermaJ Invest Dermatol199911245646210201529
   PubMed Web of Science ®Google Scholar
• YamamotoTKurodaMNishiokaKAnimal model of sclerotic skin. III: histopathological comparison of bleomycin-induced scleroderma in various mice strainsArch Dermatol Res200029253554111194891
   PubMed Web of Science ®Google Scholar
• YamamotoTKatayamaIVascular changes in bleomycin-induced sclerodermaInt J Rheumatol2011201127093822028717
   PubMedGoogle Scholar
• ClementsPJHurwitzELWongWKSkin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trialArthritis Rheum2000432445245411083267
   PubMed Web of Science ®Google Scholar
• ArtlettCMSassi-GahaSRiegerJLBoesteanuACFeghali-BostwickCAKatsikisPDThe inflammasome activating caspase-1 mediates fibrosis and myofibroblast differentiation in systemic sclerosisArthritis Rheum2011633563357421792841
   PubMed Web of Science ®Google Scholar
• MouratisMAAidinisVModeling pulmonary fibrosis with bleomycinCurr Opin Pulm Med20111735536121832918
   PubMed Web of Science ®Google Scholar
• Santos-SilvaMAPiresKMTrajanoETRedox imbalance and pulmonary function in bleomycin-induced fibrosis in C57BL/6, DBA/2, and BALB/c miceToxicol Pathol20124073174122549973
   PubMed Web of Science ®Google Scholar
• LeeRReeseCBonnerMBleomycin delivery by osmotic mini-pump: similarity to human scleroderma interstitial lung diseaseAm J Physiol Lung Cell Mol Physiol2014306L736L74824583879
   PubMed Web of Science ®Google Scholar
• HeidMEKeyelPAKamgaCShivaSWatkinsSCSalterRDMitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activationJ Immunol20131915230523824089192
   PubMed Web of Science ®Google Scholar
• ZhouRYazdiASMenuPTschoppJA role for mitochondria in NLRP3 inflammasome activationNature201146922122521124315
   PubMed Web of Science ®Google Scholar
• LiuRChenHBaiHSuppression of nuclear factor erythroid 2-related factor 2 via extracellular signal-regulated kinase contributes to bleomycin-induced oxidative stress and fibrogenesisToxicol Lett2013220152523570914
   PubMed Web of Science ®Google Scholar
• CortAOzdemirETimurMOzbenTEffects of N-acetyl-L-cysteine on bleomycin induced oxidative stress in malignant testicular germ cell tumorsBiochimie2012942734273922940535
   PubMed Web of Science ®Google Scholar
• BrarSSMeyerJNBortnerCDVan HoutenBMartinWJ2ndMitochondrial DNA-depleted A549 cells are resistant to bleomycinAm J Physiol Lung Cell Mol Physiol2012303L413L42422773697
   PubMed Web of Science ®Google Scholar
• ZhouCFYuJFZhangJXN-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of sclerodermaClin Exp Dermatol20133840340923517443
   PubMed Web of Science ®Google Scholar
• FeldmeyerLWernerSFrenchLEBeerHDInterleukin-1, inflammasomes and the skinEur J Cell Biol20108963864420605059
   PubMed Web of Science ®Google Scholar
• MortazEHenricksPAKraneveldADGiviMEGarssenJFolkertsGCigarette smoke induces the release of CXCL-8 from human bronchial epithelial cells via TLRs and induction of the inflammasomeBiochim Biophys Acta201118121104111021684332
   PubMed Web of Science ®Google Scholar
• IshikawaHTakedaKOkamotoAMatsuoSIsobeKInduction of autoimmunity in a bleomycin-induced murine model of experimental systemic sclerosis: an important role for CD4+ T cellsJ Invest Dermatol20091291688169519158840
   PubMed Web of Science ®Google Scholar
• SamboPJanninoLCandelaMMonocytes of patients with systemic sclerosis (scleroderma) spontaneously release in vitro increased amounts of superoxide anionJ Invest Dermatol199911278849886268
   PubMed Web of Science ®Google Scholar
• SamboPBaroniSSLuchettiMOxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathwayArthritis Rheum2001442653266411710721
   PubMed Web of Science ®Google Scholar
• BhandaryBMarahattaAKimHRChaeHJAn involvement of oxidative stress in endoplasmic reticulum stress and its associated diseasesInt J Mol Sci20121443445623263672
   PubMed Web of Science ®Google Scholar
• ServettazAGoulvestreCKavianNSelective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouseJ Immunol20091825855586419380834
   PubMed Web of Science ®Google Scholar
• ServettazAKavianNNiccoCTargeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosisAm J Pathol201017718719620508030
   PubMed Web of Science ®Google Scholar
• BatteuxFKavianNServettazANew insights on chemically induced animal models of systemic sclerosisCurr Opin Rheumatol20112351151821857225
   PubMed Web of Science ®Google Scholar
• BagnatoGBittoAIrreraNPropylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosisArthritis Res Ther201315R12024286160
   PubMed Web of Science ®Google Scholar
• McCormickLLZhangYTootellEGilliamACAnti-TGF-á treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human sclerodermaJ Immunol19991635693569910553100
   PubMed Web of Science ®Google Scholar
• ZhangYMcCormickLLDesaiSRWuCGilliamACMurine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activationJ Immunol20021683088309811884483
   PubMed Web of Science ®Google Scholar
• MavaliaCScalettiCRomagnaniPType 2 helper T-cell predominance and high CD30 expression in systemic sclerosisAm J Pathol1997151175117589403725
   PubMed Web of Science ®Google Scholar
• RuzekMCJhaSLedbetterSRichardsSMGarmanRDA modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human diseaseArthritis Rheum2004501319133115077316
   PubMed Web of Science ®Google Scholar
• StawskiLHanRBujorAMTrojanowskaMAngiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosisArthritis Res Ther201214R19422913887
   PubMed Web of Science ®Google Scholar
• ZhaoQIshibashiMHiasaKTanCTakeshitaAEgashiraKEssential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodelingHypertension20044426427015262905
   PubMed Web of Science ®Google Scholar
• MarutWKavianNServettazAAmelioration of systemic fibrosis in mice by angiotensin II receptor blockadeArthritis Rheum2013651367137723335130
   PubMed Web of Science ®Google Scholar
• KawaguchiYTakagiKHaraMAngiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptorsArthritis Rheum20045021622614730619
   PubMed Web of Science ®Google Scholar
• YoshizakiAYanabaKOgawaAAsanoYKadonoTSatoSImmunization with DNA topoisomerase I and Freund’s complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signalingArthritis Rheum2011633575358521792823
   PubMed Web of Science ®Google Scholar
• AbrahamDDashwoodMEndothelin – role in vascular diseaseRheumatology200847Suppl 5v23v2418784133
   PubMed Web of Science ®Google Scholar
• BouallegueADaouGBSrivastavaAKEndothelin-1-induced signaling pathways in vascular smooth muscle cellsCurr Vasc Pharmacol20075455217266612
   PubMed Web of Science ®Google Scholar
• MarasciuloFLMontagnaniMPotenzaMAEndothelin-1: the yin and yang on vascular functionCurr Med Chem2006131655166516787211
   PubMed Web of Science ®Google Scholar
• HocherBThone-ReinekeCRohmeissPEndothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertensionJ Clin Invest199799138013899077548
   PubMed Web of Science ®Google Scholar
• HocherBSchwarzAFaganKAPulmonary fibrosis and chronic lung inflammation in ET-1 transgenic miceAm J Respir Cell Mol Biol200023192610873149
   PubMed Web of Science ®Google Scholar
• VancheeswaranRMagoulasTEfratGCirculating endothelin-1 levels in systemic sclerosis subsets – a marker of fibrosis or vascular dysfunction?J Rheumatol199421183818447837147
   PubMed Web of Science ®Google Scholar
• KawaguchiYSuzukiKHaraMIncreased endothelin-1 production in fibroblasts derived from patients with systemic sclerosisAnn Rheum Dis1994535065107944634
   PubMed Web of Science ®Google Scholar
• RubinLJBadeschDBBarstRJBosentan therapy for pulmonary arterial hypertensionN Engl J Med200234689690311907289
   PubMed Web of Science ®Google Scholar
• JoglekarATsaiFSMcCloskeyDAWilsonJESeiboldJRRileyDJBosentan in pulmonary arterial hypertension secondary to sclerodermaJ Rheumatol200633616816395751
   PubMed Web of Science ®Google Scholar
• MarieIBenyJLEndothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1J Invest Dermatol20021191379138712485443
   PubMed Web of Science ®Google Scholar
• RichardVSolansVFavreJRole of endogenous endothelin in endothelial dysfunction in murine model of systemic sclerosis: tight skin mice 1Fundam Clin Pharmacol20082264965519049669
   PubMed Web of Science ®Google Scholar
• MaurerBBuschNJungelATranscription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosisCirculation20091202367237619933934
   PubMed Web of Science ®Google Scholar
• MaurerBDistlerJHDistlerOThe Fra-2 transgenic mouse model of systemic sclerosisVasc Pharmacol201358194201
   PubMed Web of Science ®Google Scholar
• SonnylalSDentonCPZhengBPostnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of sclerodermaArthritis Rheum20075633434417195237
   PubMed Web of Science ®Google Scholar
• RabquerBJKochAEAngiogenesis and vasculopathy in systemic sclerosis: evolving conceptsCurr Rheumatol Rep201214566322083296
   PubMed Web of Science ®Google Scholar
• FlemingJNNashRAMahoneyWMJrSchwartzSMIs scleroderma a vasculopathy?Curr Rheumatol Rep20091110311019296882
   PubMedGoogle Scholar
• KoenigMJoyalFFritzlerMJAutoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosisArthritis Rheum2008583902391219035499
   PubMed Web of Science ®Google Scholar
• Bou-GhariosGGarrettLARossertJA potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic miceJ Cell Biol1996134133313448794872
   PubMed Web of Science ®Google Scholar
• DentonCPZhengBEvansLAFibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic miceJ Biol Chem2003278251092511912707256
   PubMed Web of Science ®Google Scholar
• DentonCPLindahlGEKhanKActivation of key profibrotic mechanisms in transgenic fibroblasts expressing kinase-deficient type II transforming growth factor-{beta} receptor (T{beta}RII{delta}k)J Biol Chem2005280160531606515708853
   PubMed Web of Science ®Google Scholar
• Derrett-SmithECDooleyAGilbaneAJEndothelial injury in a transforming growth factor beta-dependent mouse model of scleroderma induces pulmonary arterial hypertensionArthritis Rheum2013652928293923839959
   PubMed Web of Science ®Google Scholar
• OverbeekMJBoonstraAVoskuylAEPlatelet-derived growth factor receptor-beta and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control studyArthritis Res Ther201113R6121492463
   PubMed Web of Science ®Google Scholar
• TrojanowskaMRole of PDGF in fibrotic diseases and systemic sclerosisRheumatology200847Suppl 5v2v418784131
   PubMed Web of Science ®Google Scholar
• OlsonLESorianoPIncreased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosisDev Cell20091630331319217431
   PubMed Web of Science ®Google Scholar
• KavianNServettazAMarutWSunitinib inhibits the phosphorylation of platelet-derived growth factor receptor beta in the skin of mice with scleroderma-like features and prevents the development of the diseaseArthritis Rheum2012641990200022213155
   PubMed Web of Science ®Google Scholar
• RazaniBWoodmanSELisantiMPCaveolae: from cell biology to animal physiologyPharmacol Rev20025443146712223531
   PubMed Web of Science ®Google Scholar
• DrabMVerkadePElgerMLoss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted miceScience20012932449245211498544
   PubMed Web of Science ®Google Scholar
• Castello-CrosRWhitaker-MenezesDMolchanskyAScleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosisCell Cycle2011102140215021670602
   PubMed Web of Science ®Google Scholar
• RazaniBZhangXLBitzerMvon GersdorffGBottingerEPLisantiMPCaveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptorJ Biol Chem20012766727673811102446
   PubMed Web of Science ®Google Scholar
• TourkinaEGoozPPannuJOpposing effects of protein kinase Cà and protein kinase Cî on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signalingJ Biol Chem2005280138791388715691837
   PubMed Web of Science ®Google Scholar
• WangXMZhangYKimHPCaveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosisJ Exp Med20062032895290617178917
   PubMed Web of Science ®Google Scholar
• PavlidesSTsirigosAVeraILoss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the “reverse Warburg effect”: a transcriptional informatics analysis with validationCell Cycle201092201221920519932
   PubMed Web of Science ®Google Scholar
• AvouacJBorderieDEkindjianOGKahanAAllanoreYHigh DNA oxidative damage in systemic sclerosisJ Rheumatol201037122540254720843906
   PubMed Web of Science ®Google Scholar
• ErreGLDe MuroPDellacaPIloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosisClin Exp Rheumatol2008261095109819210877
   PubMed Web of Science ®Google Scholar
• LiangSHZhangWMcGrathBCZhangPCavenerDRPERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasisBiochem J200639320120916124869
   PubMed Web of Science ®Google Scholar
• WuMMelichianDSde la GarzaMEssential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healingAm J Pathol20091751041105519679873
   PubMed Web of Science ®Google Scholar
• AsanoYStawskiLHantFEndothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathyAm J Pathol20101761983199820228226
   PubMed Web of Science ®Google Scholar
• NakerakantiSSKapanadzeBYamasakiMMarkiewiczMTrojanowskaMFli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene programJ Biol Chem2006281252592526916829517
   PubMed Web of Science ®Google Scholar
• FlemingJNNashRAMahoneyWMJrSchwartzSMIs scleroderma a vasculopathy?Curr Rheumatol Rep20091110311019296882
   PubMedGoogle Scholar
• AsanoYMarkiewiczMKuboMSzalaiGWatsonDKTrojanowskaMTranscription factor Fli1 regulates collagen fibrillogenesis in mouse skinMol Cell Biol20092942543419001092
   PubMed Web of Science ®Google Scholar
• ChujoSShirasakiFKondo-MiyazakiMIkawaYTakeharaKRole of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosisJ Cell Physiol200922018919519277979
   PubMed Web of Science ®Google Scholar
• WangXLiXYeLChenWYuXSmad7 inhibits TGF-beta1-induced MCP-1 upregulation through a MAPK/p38 pathway in rat peritoneal mesothelial cellsInt Urol Nephrol20134589990723242502
   PubMed Web of Science ®Google Scholar
• JonesSGMorriseyKWilliamsJDPhillipsAOTGF-beta1 stimulates the release of pre-formed bFGF from renal proximal tubular cellsKidney Int199956839110411682
   PubMed Web of Science ®Google Scholar
• TallEGBernsteinAMOliverNGrayJLMasurSKTGF-beta-stimulated CTGF production enhanced by collagen and associated with biogenesis of a novel 31-kDa CTGF form in human corneal fibroblastsInvest Ophthalmol Vis Sci2010515002501120393108
   PubMed Web of Science ®Google Scholar
• McCannMRMonemdjouRGhassemi-KakroodiPmPGES-1 null mice are resistant to bleomycin-induced skin fibrosisArthritis Res Ther201113R621266028
   PubMed Web of Science ®Google Scholar
• WuMMelichianDSChangEWarner-BlankenshipMGhoshAKVargaJRosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gammaAm J Pathol200917451953319147827
   PubMed Web of Science ®Google Scholar
• GhoshAKBhattacharyyaSLakosGChenSJMoriYVargaJDisruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gammaArthritis Rheum2004501305131815077315
   PubMed Web of Science ®Google Scholar
• WeiJGhoshAKSargentJLPPARgamma downregulation by TGFβ in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesisPLoS One20105e1377821072170
   PubMed Web of Science ®Google Scholar
• KapoorMMcCannMLiuSLoss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosisArthritis Rheum2009602822282919714649
   PubMed Web of Science ®Google Scholar
• CheangWSFangXTianXYPleiotropic effects of peroxisome proliferator-activated receptor gamma and delta in vascular diseasesCirculation J20137726642671
   Web of Science ®Google Scholar
• LuYAzadNWangLPhosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen productionAm J Resp Cell Mol Biol201042432441
   PubMed Web of Science ®Google Scholar
• Shi-WenXChenYDentonCPEndothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblastsMol Biol Cell2004152707271915047866
   PubMed Web of Science ®Google Scholar
• ParapuramSKShi-wenXElliottCLoss of PTEN expression by dermal fibroblasts causes skin fibrosisJ Invest Dermatol20111311996200321654839
   PubMed Web of Science ®Google Scholar
• TangMLSamuelCSRoyceSGRole of relaxin in regulation of fibrosis in the lungAnn N Y Acad Sci2009116034234719416216
   PubMed Web of Science ®Google Scholar
• HuangXGaiYYangNRelaxin regulates myofibroblast contractility and protects against lung fibrosisAm J Pathol20111792751276521983071
   PubMed Web of Science ®Google Scholar
• SamuelCSZhaoCYangQThe relaxin gene knockout mouse: a model of progressive sclerodermaJ Invest Dermatol200512569269916185267
   PubMed Web of Science ®Google Scholar
• BennettRGHeimannDGSinghSSimpsonRLTumaDJRelaxin decreases the severity of established hepatic fibrosis in miceLiver Int20133441642623870027
   PubMed Web of Science ®Google Scholar
• SassoliCChelliniFPiniARelaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-beta/Smad3 signalingPLoS One20138e6389623704950
   PubMed Web of Science ®Google Scholar
• LiXFLiaoJXinZQLuWQLiuALRelaxin attenuates silica-induced pulmonary fibrosis by regulating collagen type I and MMP-2Int Immunopharmacol20131753754223973652
   PubMed Web of Science ®Google Scholar
• GassePMaryCGuenonIIL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in miceJ Clin Invest20071173786379917992263
   PubMed Web of Science ®Google Scholar
• SendelbachLELindenschmidtRCWitschiHPThe effect of cyclosporin A on pulmonary fibrosis induced by butylated hydroxytoluene, bleomycin and beryllium sulfateToxicol Lett198561691732412310
   PubMed Web of Science ®Google Scholar
• LossosISOrRGoldsteinRHConnerMWBreuerRAmelioration of bleomycin-induced pulmonary injury by cyclosporin AExp Lung Res199622237249
   Web of Science ®Google Scholar
• BassoMFilaciGCutoloMLong-term treatment of patients affected by systemic sclerosis with cyclosporin AAnn Ital Med Int20011623323911799631
   PubMedGoogle Scholar
• MannoRBoinFImmunotherapy of systemic sclerosisImmunotherapy2010286387821091117
   PubMed Web of Science ®Google Scholar
• GuillevinLBerezneASerorRScleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controlsRheumatology20125146046722087012
   PubMed Web of Science ®Google Scholar
• OzgenMKocaSSDagliAFGundogduBUstundagBIsikAMycophenolate mofetil and daclizumab targeting T lymphocytes in bleomycin-induced experimental sclerodermaClin Exp Dermatol201237485422182434
   PubMed Web of Science ®Google Scholar
• MendozaFANagleSJLeeJBJimenezSAA prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onsetJ Rheumatol2012391241124722467932
   PubMed Web of Science ®Google Scholar
• SinghalSMehtaJThalidomide in cancerBiomed Pharmacother20025641211905508
   PubMed Web of Science ®Google Scholar
• OliverSJMoreiraAKaplanGImmune stimulation in scleroderma patients treated with thalidomideClin Immunol20009710912011027451
   PubMed Web of Science ®Google Scholar
• ZhangLZhuYLuoWXiPYanYThe protective effect of colchicine on bleomycin-induced pulmonary fibrosis in ratsChin Med Sci J1992758601384784
   PubMedGoogle Scholar
• GuttadauriaMDiamondHKaplanDColchicine in the treatment of sclerodermaJ Rheumatol19774272276926103
   PubMed Web of Science ®Google Scholar
• FrayhaRAColchicine therapy in scleroderma. Preliminary resultsDermatologica19791597881478046
   PubMedGoogle Scholar
• KocaSSIsikAOzercanIHUstundagBEvrenBMetinKEffectiveness of etanercept in bleomycin-induced experimental sclerodermaRheumatology20084717217518174229
   PubMed Web of Science ®Google Scholar
• LamGKHummersLKWoodsAWigleyFMEfficacy and safety of etanercept in the treatment of scleroderma-associated joint diseaseJ Rheumatol2007341636163717611970
   PubMed Web of Science ®Google Scholar
• JacksonRMFellCDEtanercept for idiopathic pulmonary fibrosis: lessons on clinical trial designAm J Resp Crit Care Med200817888989118945868
   PubMed Web of Science ®Google Scholar
• AllanoreYDevos-FrancoisGCaramellaCBoumierPJounieauxVKahanAFatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumabAnn Rheum Dis20066583483516699057
   PubMed Web of Science ®Google Scholar
• PreySEzzedineKDoussauAImatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trialBr J Dermatol20121671138114423039171
   PubMed Web of Science ®Google Scholar
• AytemurZAHacievliyagilSSIrazMEffects of iloprost on bleomycin-induced pulmonary fibrosis in rats compared with methyl-prednisoloneRev Port Pneumol20121827227722770817
   PubMed Web of Science ®Google Scholar
• BaliGSchwantzerGAbererFKraenkeBAbererEDiscontinuing long-term Iloprost treatment for Raynaud’s phenomenon and systemic sclerosis: a single-center, randomized, placebo-controlled, double-blind studyActa Dermatovenerol Alp Panonica Adriat2011201321
   Google Scholar
• TingeyTShuJSmuczekJPopeJMeta-analysis of healing and prevention of digital ulcers in systemic sclerosisArthritis Care Res20136514601471
   PubMed Web of Science ®Google Scholar
• NelsonEFHuangCWEwelJMChangAAYuanCHalofuginone down-regulates Smad3 expression and inhibits the TGFbeta-induced expression of fibrotic markers in human corneal fibroblastsMol Vis20121847948722393274
   PubMed Web of Science ®Google Scholar
• PinesMSnyderDYarkoniSNaglerAHalofuginone to treat fibrosis in chronic graft-versus-host disease and sclerodermaBiol Blood Marrow Transplant2003941742512869955
   PubMed Web of Science ®Google Scholar
• PennHQuillinanNKhanKTargeting the endothelin axis in scleroderma renal crisis: rationale and feasibilityQJM201310683984823696678
   PubMed Web of Science ®Google Scholar
• GuiducciSBellando RandoneSBruniCBosentan fosters microvascular de-remodelling in systemic sclerosisClin Rheumatol2012311723173523053682
   PubMed Web of Science ®Google Scholar
• Molina-MolinaMSerrano-MollarABulbenaOLosartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesisThorax20066160461016601095
   PubMed Web of Science ®Google Scholar
• YaoHWZhuJPZhaoMHLuYLosartan attenuates bleomycin-induced pulmonary fibrosis in ratsRespiration20067323624216330873
   PubMed Web of Science ®Google Scholar
• KhannaDClementsPJFurstDERecombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trialArthritis Rheum2009601102111119333948
   PubMed Web of Science ®Google Scholar
• LeCHMoralesATrenthamDEMinocycline in early diffuse sclerodermaLancet1998352175517569848358
   PubMed Web of Science ®Google Scholar
• MayesMDO’DonnellDRothfieldNFCsukaMEMinocycline is not effective in systemic sclerosis: results of an open-label multicenter trialArthritis Rheum20045055355714872498
   PubMed Web of Science ®Google Scholar
• Krishna SumanthMSharmaVKKhaitanBKKapoorATejasviTEvaluation of oral methotrexate in the treatment of systemic sclerosisInt J Dermatol20074621822317269983
   PubMed Web of Science ®Google Scholar
• ZulianFVallongoCPatriziAA long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea)J Am Acad Dermatol2012671151115622657157
   PubMed Web of Science ®Google Scholar
• OzgenMKocaSSIsikAOzercanIHMethotrexate has no antifibrotic effect in bleomycin-induced experimental sclerodermaJ Rheumatol20103767867920197571
   PubMed Web of Science ®Google Scholar
• SabaKhanSParvezSEllagic acid attenuates bleomycin and cyclophosphamide-induced pulmonary toxicity in Wistar ratsFood Chem Toxicol20135821021923603381
   PubMed Web of Science ®Google Scholar
• AndoKMotojimaSDoiTEffect of glucocorticoid mono-therapy on pulmonary function and survival in Japanese patients with scleroderma-related interstitial lung diseaseRespir Investig2013516975
   PubMedGoogle Scholar
• FarinaACironeMYorkMEpstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in sclerodermaJ Invest Dermatol201413495496424129067
   PubMed Web of Science ®Google Scholar
• FujiwaraSReproduction of Epstein-Barr virus infection and pathogenesis in humanized miceImmune Netw2014141624605074
   PubMedGoogle Scholar
• MedinaFAde AlmeidaCJDewECaveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infectionInfect Immun2006746665667416982844
   PubMed Web of Science ®Google Scholar
• ParkSHSalehDGiaidAMichelRPIncreased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonistAm J Resp Crit Care Med19971566006089279246
   PubMed Web of Science ®Google Scholar
• Alarcon-SegoviaDRamos-NiembroFIbanez de KasepGAlcocerJTamayoRPLong-term evaluation of colchicine in the treatment of sclerodermaJ Rheumatol19796705712529256
   PubMed Web of Science ®Google Scholar
• TrivediRRedenteEFThakurARichesDWKompellaUBLocal delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in miceNanotechnology20122350510123186914
   PubMed Web of Science ®Google Scholar
• KehrerJPMargolinSBPirfenidone diminishes cyclophosphamide-induced lung fibrosis in miceToxicol Lett1997901251329067480
   PubMed Web of Science ®Google Scholar
• AntoniuSAPirfenidone for the treatment of idiopathic pulmonary fibrosisExpert Opin Investig Drugs200615823828
   PubMed Web of Science ®Google Scholar
• SeiboldJRKornJHSimmsRRecombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trialAnn Intern Med200013287187910836913
   PubMed Web of Science ®Google Scholar
• JordanSDistlerJHMaurerBon behalf of the EUSTAR Rituximab Study GroupEffects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) groupAnn Rheum Dis Epub2014117
   Google Scholar
• DeesCAkhmetshinaAZerrPPlatelet-derived serotonin links vascular disease and tissue fibrosisJ Exp Med201120896197221518801
   PubMed Web of Science ®Google Scholar
• TabataCTabataRKadokawaYThalidomide prevents bleomycin-induced pulmonary fibrosis in miceJ Immunol200717970871417579094
   PubMed Web of Science ®Google Scholar
• WeingartnerSZerrPTomcikMPomalidomide is effective for prevention and treatment of experimental skin fibrosisAnn Rheum Dis2012711895189922904257
   PubMed Web of Science ®Google Scholar